Incyte Corp. (INCY)
97.42
+0.34
(+0.35%)
USD |
NASDAQ |
May 21, 16:00
97.80
+0.38
(+0.39%)
After-Hours: 19:59
Incyte EPS Diluted (Quarterly) : 1.467 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Eli Lilly & Co. | 8.255 |
| Madrigal Pharmaceuticals, Inc. | -3.251 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Insmed, Inc. | -0.7591 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 303.33M |
| Revenue (Quarterly) | 1.273B |
| Total Expenses (Quarterly) | 969.35M |
| Enterprise Value | 15.42B |
| Gross Profit Margin (Quarterly) | 90.46% |
| Profit Margin (Quarterly) | 23.83% |
| Earnings Yield | 7.26% |
| Operating Earnings Yield | 7.34% |
| Normalized Earnings Yield | 6.632 |